Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 91 (PPIAP91) is a processed pseudogene related to the functional gene peptidylprolyl isomerase A (PPIA), which encodes the enzyme cyclophilin A. PPIAP91 does not encode a functional protein and is classified as a pseudogene, meaning it arises from gene duplication or retrotransposition events, but has lost the ability to code for a protein product[3]. While some pseudogenes can act as regulatory long non-coding RNAs—impacting gene expression through various RNA-mediated mechanisms—there is no direct scientific evidence in the current literature that PPIAP91 has a known biological function, role in disease, or any value as a therapeutic target, biomarker, or drug-interacting molecule[3]. The confusion often arises because closely related pseudogenes, such as PPIAP22, have been reported in research to modulate cancer biology as long non-coding RNAs, but no such data exists for PPIAP91 specifically[4][7].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 91 (PPIAP91).